Your browser doesn't support javascript.
loading
Multicenter clinical evaluation of a novel transcription-mediated amplification assay for SARS-CoV-2 molecular testing.
Fernández-Huerta, Miguel; Salmerón, Paula; Hernández-Hermida, Yolanda; Andrés, Cristina; Niubó, Jordi; Calatayud, Laura; Domínguez, M Ángeles; Pumarola, Tomàs; Ardanuy, Carmen; Antón, Andrés; Càmara, Jordi.
Afiliação
  • Fernández-Huerta M; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Salmerón P; Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Hernández-Hermida Y; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Andrés C; Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Niubó J; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Calatayud L; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERER), ISCIII, Madrid, Spain.
  • Domínguez MÁ; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain; Department of Pathology and Experimental Therapeutics, University of
  • Pumarola T; Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Ardanuy C; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERER), ISCIII, Madrid, Spain; Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.
  • Antón A; Respiratory Viruses Unit, Microbiology Department, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Càmara J; Microbiology Department, Hospital Universitari Bellvitge, University of Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain; CIBER de Enfermedades Respiratorias (CIBERER), ISCIII, Madrid, Spain. Electronic address: jcamara@bellvitgehospital.cat.
Enferm Infecc Microbiol Clin (Engl Ed) ; 41(8): 462-467, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37076332
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Enferm Infecc Microbiol Clin (Engl Ed) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Enferm Infecc Microbiol Clin (Engl Ed) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha